208 related articles for article (PubMed ID: 26862848)
1. Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.
Marien E; Meister M; Muley T; Gomez Del Pulgar T; Derua R; Spraggins JM; Van de Plas R; Vanderhoydonc F; Machiels J; Binda MM; Dehairs J; Willette-Brown J; Hu Y; Dienemann H; Thomas M; Schnabel PA; Caprioli RM; Lacal JC; Waelkens E; Swinnen JV
Oncotarget; 2016 Mar; 7(11):12582-97. PubMed ID: 26862848
[TBL] [Abstract][Full Text] [Related]
2. Development of a high-density assay for long-chain fatty acyl-CoA elongases.
Kitazawa H; Miyamoto Y; Shimamura K; Nagumo A; Tokita S
Lipids; 2009 Aug; 44(8):765-73. PubMed ID: 19575253
[TBL] [Abstract][Full Text] [Related]
3. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a potent inhibitor for mammalian elongase of long-chain fatty acids family 6: examination of its potential utility as a pharmacological tool.
Shimamura K; Kitazawa H; Miyamoto Y; Kanesaka M; Nagumo A; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
J Pharmacol Exp Ther; 2009 Jul; 330(1):249-56. PubMed ID: 19359527
[TBL] [Abstract][Full Text] [Related]
4. Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
Marien E; Meister M; Muley T; Fieuws S; Bordel S; Derua R; Spraggins J; Van de Plas R; Dehairs J; Wouters J; Bagadi M; Dienemann H; Thomas M; Schnabel PA; Caprioli RM; Waelkens E; Swinnen JV
Int J Cancer; 2015 Oct; 137(7):1539-48. PubMed ID: 25784292
[TBL] [Abstract][Full Text] [Related]
5. Elo1p-dependent carboxy-terminal elongation of C14:1Delta(9) to C16:1Delta(11) fatty acids in Saccharomyces cerevisiae.
Schneiter R; Tatzer V; Gogg G; Leitner E; Kohlwein SD
J Bacteriol; 2000 Jul; 182(13):3655-60. PubMed ID: 10850979
[TBL] [Abstract][Full Text] [Related]
6. High-throughput assay for long chain fatty acyl-CoA elongase using homogeneous scintillation proximity format.
Shimamura K; Miyamoto Y; Kitazawa H; Kobayashi T; Kotani H; Tokita S
Assay Drug Dev Technol; 2009 Apr; 7(2):124-32. PubMed ID: 19505229
[TBL] [Abstract][Full Text] [Related]
7. ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
Centenera MM; Scott JS; Machiels J; Nassar ZD; Miller DC; Zinonos I; Dehairs J; Burvenich IJG; Zadra G; Chetta PM; Bango C; Evergren E; Ryan NK; Gillis JL; Mah CY; Tieu T; Hanson AR; Carelli R; Bloch K; Panagopoulos V; Waelkens E; Derua R; Williams ED; Evdokiou A; Cifuentes-Rius A; Voelcker NH; Mills IG; Tilley WD; Scott AM; Loda M; Selth LA; Swinnen JV; Butler LM
Cancer Res; 2021 Apr; 81(7):1704-1718. PubMed ID: 33547161
[TBL] [Abstract][Full Text] [Related]
8. Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance.
Moon YA; Ochoa CR; Mitsche MA; Hammer RE; Horton JD
J Lipid Res; 2014 Dec; 55(12):2597-605. PubMed ID: 25281760
[TBL] [Abstract][Full Text] [Related]
9. Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6.
Tan CY; Virtue S; Bidault G; Dale M; Hagen R; Griffin JL; Vidal-Puig A
Cell Rep; 2015 Dec; 13(10):2039-47. PubMed ID: 26628376
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a selective radioligand for ELOVL6.
Shimamura K; Takahashi H; Kitazawa H; Miyamoto Y; Nagumo A; Tang C; Dean D; Nagase T; Sato N; Tokita S
J Biochem; 2009 Sep; 146(3):429-37. PubMed ID: 19505953
[TBL] [Abstract][Full Text] [Related]
11. Two modes of regulation of the fatty acid elongase ELOVL6 by the 3-ketoacyl-CoA reductase KAR in the fatty acid elongation cycle.
Naganuma T; Kihara A
PLoS One; 2014; 9(7):e101823. PubMed ID: 25003994
[TBL] [Abstract][Full Text] [Related]
12. Two Elongases, Elovl4 and Elovl6, Fulfill the Elongation Routes of the LC-PUFA Biosynthesis Pathway in the Orange Mud Crab (
Ting SY; Janaranjani M; Merosha P; Sam KK; Wong SC; Goh PT; Mah MQ; Kuah MK; Chong Shu-Chien A
J Agric Food Chem; 2020 Apr; 68(14):4116-4130. PubMed ID: 32186869
[TBL] [Abstract][Full Text] [Related]
13. Mammalian fatty acid elongases.
Jump DB
Methods Mol Biol; 2009; 579():375-89. PubMed ID: 19763486
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo.
Liu G; Wu Q; Liu G; Song X; Zhang J
Int J Clin Exp Pathol; 2014; 7(11):8279-89. PubMed ID: 25550886
[TBL] [Abstract][Full Text] [Related]
15. Elovl6: a new player in fatty acid metabolism and insulin sensitivity.
Matsuzaka T; Shimano H
J Mol Med (Berl); 2009 Apr; 87(4):379-84. PubMed ID: 19259639
[TBL] [Abstract][Full Text] [Related]
16. Long-chain polyunsaturated fatty acid biosynthesis in a land-crab with advanced terrestrial adaptations: Molecular cloning and functional characterization of two fatty acyl elongases.
Ting SY; Lau NS; Sam KK; Janaranjani M; Wong SC; Monroig Ó; Quah ESH; Ahmad AB; Him NAIIN; Jaya-Ram A; Shu-Chien AC
Comp Biochem Physiol B Biochem Mol Biol; 2022; 262():110773. PubMed ID: 35718326
[TBL] [Abstract][Full Text] [Related]
17. In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model.
Rudy SF; Brenner JC; Harris JL; Liu J; Che J; Scott MV; Owen JH; Komarck CM; Graham MP; Bellile EL; Bradford CR; Prince ME; Carey TE
J Otolaryngol Head Neck Surg; 2016 Apr; 45():26. PubMed ID: 27117272
[TBL] [Abstract][Full Text] [Related]
18. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis.
Ohno Y; Suto S; Yamanaka M; Mizutani Y; Mitsutake S; Igarashi Y; Sassa T; Kihara A
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18439-44. PubMed ID: 20937905
[TBL] [Abstract][Full Text] [Related]
19. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
[TBL] [Abstract][Full Text] [Related]
20. Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression.
Su YC; Feng YH; Wu HT; Huang YS; Tung CL; Wu P; Chang CJ; Shiau AL; Wu CL
Sci Rep; 2018 Apr; 8(1):6586. PubMed ID: 29700319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
